Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Enterprise Value (2010 - 2026)

Vericel (VCEL) posted Enterprise Value of -$162.5 million for Q2 2026, down 11.8% sequentially from -$145.3 million in Q1 2026, and down 39.03% YoY from -$266.5 million in Q2 2025.

Analysis

Vericel (VCEL) Enterprise Value (2010 - 2026) Analysis & Trends

Vericel has reported Enterprise Value for 15 years, with the latest figure at -$162.5 million in Q2 2026.

  • Quarterly Enterprise Value fell 39.03% year-over-year to -$162.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$162.5 million (down 39.03% YoY) and the FY2025 annual result came in at -$137.5 million, down 18.32% from the prior year.
  • Enterprise Value declined to -$162.5 million in Q2 2026 per VCEL's latest filing, from -$145.3 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$97.8 million in Q2 2023 and troughed at -$162.5 million in Q2 2026.
  • A 5-year average of -$117.0 million and a median of -$111.9 million in 2022 frame the typical range for Enterprise Value.
  • The sharpest annual moves came in 2023 and 2026: Enterprise Value gained 8.35% in 2023, then slumped 39.03% in 2026.
  • Over 5 years, Enterprise Value stood at -$119.5 million in 2022, then grew by 8.35% to -$109.6 million in 2023, then fell by 6.08% to -$116.2 million in 2024, then fell by 18.32% to -$137.5 million in 2025, then retreated by 18.18% to -$162.5 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$162.5 million, -$145.3 million, and -$137.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.11 Bn
Mar 31, 2026 1.50 Bn
Dec 31, 2025 1.69 Bn
Sep 30, 2025 1.46 Bn
Jun 30, 2025 2.03 Bn
Mar 31, 2025 2.13 Bn
Dec 31, 2024 2.61 Bn
Sep 30, 2024 1.98 Bn
Jun 30, 2024 2.14 Bn
Mar 31, 2024 2.41 Bn
Dec 31, 2023 1.59 Bn
Sep 30, 2023 1.49 Bn
Jun 30, 2023 1.69 Bn
Mar 31, 2023 1.27 Bn
Dec 31, 2022 1.13 Bn
Sep 30, 2022 984.12 Mn
Jun 30, 2022 1.09 Bn
Mar 31, 2022 1.70 Bn
Dec 31, 2021 1.74 Bn
Sep 30, 2021 2.18 Bn